Pharmala Biotech Holdings Inc. (CSE:MDMA)
Canada · Delayed Price · Currency is CAD 0.2150
+0.0050 (2.38%)
Oct 9, 2026, 3:54 PM EST
Pharmala Biotech Holdings Market Cap
Pharmala Biotech Holdings has a market cap or net worth of CAD 23.58 million as of October 9, 2026. It is the 38,464th most valuable company in the world and the 1,257th biggest in Canada. Its market cap has increased by 80.95% in one year.
Market Cap
23.58M
Enterprise Value
23.33M
Revenue
1.27M
Global Rank
Country Rank
#1,257 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since January 11, 2022, Pharmala Biotech Holdings's market cap has increased from 6.64M to 23.58M, an increase of 255.14%. That is a compound annual growth rate of 30.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 23.58M | 96.88% |
| Dec 31, 2025 | 11.98M | -53.64% |
| Dec 31, 2024 | 25.84M | 112.35% |
| Dec 29, 2023 | 12.17M | 486.37% |
| Dec 30, 2022 | 2.07M | -68.75% |
| Jan 11, 2022 | 6.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Thiogenesis Therapeutics | 34.29M |
| Telescope Innovations | 33.54M |
| The More Life Company | 31.99M |
| Resverlogix | 29.26M |
| Defence Therapeutics | 28.80M |
| Devonian Health Group | 22.25M |
| Onco-Innovations | 22.15M |
| Alzai Health | 20.09M |